These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36111490)

  • 21. Unfavorably altered fibrin clot properties in patients with active rheumatoid arthritis.
    Kwasny-Krochin B; Gluszko P; Undas A
    Thromb Res; 2010 Jul; 126(1):e11-6. PubMed ID: 20471669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thyroid dysfunction and fibrin network structure: a mechanism for increased thrombotic risk in hyperthyroid individuals.
    Hooper JM; Stuijver DJ; Orme SM; van Zaane B; Hess K; Gerdes VE; Phoenix F; Rice P; Smith KA; Alzahrani SH; Standeven KF; Ajjan RA
    J Clin Endocrinol Metab; 2012 May; 97(5):1463-73. PubMed ID: 22378816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Desialylation of fibrinogen with neuraminidase. Kinetic and clotting studies.
    Diaz-Mauriño T; Castro C; Albert A
    Thromb Res; 1982 Aug; 27(4):397-403. PubMed ID: 7147211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sensing adhesion forces between erythrocytes and γ' fibrinogen, modulating fibrin clot architecture and function.
    Guedes AF; Carvalho FA; Domingues MM; Macrae FL; McPherson HR; Santos NC; Ariёns RAS
    Nanomedicine; 2018 Apr; 14(3):909-918. PubMed ID: 29410160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The influence of type 2 diabetes on fibrin clot properties in patients with coronary artery disease.
    Neergaard-Petersen S; Hvas AM; Kristensen SD; Grove EL; Larsen SB; Phoenix F; Kurdee Z; Grant PJ; Ajjan RA
    Thromb Haemost; 2014 Dec; 112(6):1142-50. PubMed ID: 25187394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel mutation (deletion of Aalpha-Asn 80) in an abnormal fibrinogen: fibrinogen Caracas VI. Consequences of disruption of the coiled coil for the polymerization of fibrin: peculiar clot structure and diminished stiffness of the clot.
    Marchi RC; Meyer MH; de Bosch NB; Arocha-Piñango CL; Weisel JW
    Blood Coagul Fibrinolysis; 2004 Oct; 15(7):559-67. PubMed ID: 15389122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered structure and function of fibrinogen after cleavage by Factor VII Activating Protease (FSAP).
    Etscheid M; Subramaniam S; Lochnit G; Zabczyk M; Undas A; Lang IM; Hanschmann KM; Kanse SM
    Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3397-3406. PubMed ID: 30076961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Affimer proteins as a tool to modulate fibrinolysis, stabilize the blood clot, and reduce bleeding complications.
    Kearney KJ; Pechlivani N; King R; Tiede C; Phoenix F; Cheah R; Macrae FL; Simmons KJ; Manfield IW; Smith KA; Spurgeon BEJ; Naseem KM; Ariens RAS; McPherson MJ; Tomlinson DC; Ajjan RA
    Blood; 2019 Mar; 133(11):1233-1244. PubMed ID: 30545831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blood clot contraction differentially modulates internal and external fibrinolysis.
    Tutwiler V; Peshkova AD; Le Minh G; Zaitsev S; Litvinov RI; Cines DB; Weisel JW
    J Thromb Haemost; 2019 Feb; 17(2):361-370. PubMed ID: 30582674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced lysis and accelerated establishment of viscoelastic properties of fibrin clots are associated with pulmonary embolism.
    Martinez MR; Cuker A; Mills AM; Crichlow A; Lightfoot RT; Chernysh IN; Nagaswami C; Weisel JW; Ischiropoulos H
    Am J Physiol Lung Cell Mol Physiol; 2014 Mar; 306(5):L397-404. PubMed ID: 24414255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Efficacy of Fibrinogen Concentrates in Relation to Cryoprecipitate in Restoring Clot Integrity and Stability against Lysis.
    Whyte CS; Rastogi A; Ferguson E; Donnarumma M; Mutch NJ
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibrin(ogen) as a Therapeutic Target: Opportunities and Challenges.
    Gaule TG; Ajjan RA
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34203139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel mechanism for hypofibrinolysis in diabetes: the role of complement C3.
    Hess K; Alzahrani SH; Mathai M; Schroeder V; Carter AM; Howell G; Koko T; Strachan MW; Price JF; Smith KA; Grant PJ; Ajjan RA
    Diabetologia; 2012 Apr; 55(4):1103-13. PubMed ID: 21918806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of pH on the generation of turbidity and elasticity associated with fibrinogen-fibrin conversion by thrombin are remarkably influenced by sialic acid in fibrinogen.
    Okude M; Yamanaka A; Akihama S
    Biol Pharm Bull; 1995 Feb; 18(2):203-7. PubMed ID: 7742784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Controlling Fibrin Network Morphology, Polymerization, and Degradation Dynamics in Fibrin Gels for Promoting Tissue Repair.
    Sproul EP; Hannan RT; Brown AC
    Methods Mol Biol; 2018; 1758():85-99. PubMed ID: 29679324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant fibrinogen reveals the differential roles of α- and γ-chain cross-linking and molecular heterogeneity in fibrin clot strain-stiffening.
    Piechocka IK; Kurniawan NA; Grimbergen J; Koopman J; Koenderink GH
    J Thromb Haemost; 2017 May; 15(5):938-949. PubMed ID: 28166607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Whole blood clots are more resistant to lysis than plasma clots--greater efficacy of rivaroxaban.
    Varin R; Mirshahi S; Mirshahi P; Klein C; Jamshedov J; Chidiac J; Perzborn E; Mirshahi M; Soria C; Soria J
    Thromb Res; 2013 Mar; 131(3):e100-9. PubMed ID: 23313382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of Neonatal and Adult Fibrin Clot Properties between Porcine and Human Plasma.
    Nellenbach KA; Nandi S; Kyu A; Sivadanam S; Guzzetta NA; Brown AC
    Anesthesiology; 2020 May; 132(5):1091-1101. PubMed ID: 32011335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence that fibrinogen γ' directly interferes with protofibril growth: implications for fibrin structure and clot stiffness.
    Allan P; Uitte de Willige S; Abou-Saleh RH; Connell SD; Ariëns RA
    J Thromb Haemost; 2012 Jun; 10(6):1072-80. PubMed ID: 22463367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of fibrinogen carbamylation on fibrin clot formation and stability.
    Binder V; Bergum B; Jaisson S; Gillery P; Scavenius C; Spriet E; Nyhaug AK; Roberts HM; Chapple ILC; Hellvard A; Delaleu N; Mydel P
    Thromb Haemost; 2017 May; 117(5):899-910. PubMed ID: 28382370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.